Loading...
Products:Immunology >> Adaptive Immunity >> B Cells >> CD
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-CD45RO antibody [UCHL1] (FITC)
See all CD45RO products (9) ...
Mouse monoclonal [UCHL1] to CD45RO (FITC)
FITC
The antibody is conjugated with fluorescein isothiocyanate isomer 1 (FITC). The molecular F/P ratio is between 5 and 10.
ab51564 is directed against the CD45RO antigen (restricted T200, gp180), a component of the Leukocyte Common Antigen (LCA) complex, which is expressed on human T lymphocytes (40% of CD4 and 20% of CD8 positive T lymphocytes), most thymocytes and the majority of T cell malignancies. ab51564 also reacts weak with most human granulocytes and monocytes, and reacts hardly with B lymphocytes, NK cells or thrombocytes.
Flow Cyt, ICC/IFmore details
Reacts with
Human
T cell line CA1 (Human)
CD45RO positive cells in peripheral blood.
Liquid
Store at +4°C in the dark. Do not freeze.
Preservative: 0.1% Sodium Azide
Constituents: 1% BSA, PBS
Concentration information loading...
Ion Exchange Chromatography
The antibody was purified from ascites using column chromatography
This antibody would be useful for enumeration of CD45RO positive cells in peripheral blood.
Monoclonal
UCHL1
NS1
IgG2a
Immunology >> Cell Type Markers >> CD >> Non-lineage
Immunology >> Adaptive Immunity >> T Cells >> CD
Immunology >> Adaptive Immunity >> B Cells >> CD
Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)
(enlarge)
Our Abpromise guarantee covers the use of ab51564 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Flow Cyt: Use 1µl for 106 cells.
ICC/IF: Use at an assay dependent dilution.
Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.
Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.
Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.
The first PTPase domain interacts with SKAP1.
Heavily N- and O-glycosylated.
Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.
Target information above from: UniProt accessionP08575
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)
![Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)](/ps/datasheet/images/51/ab51564/CD45RO-Primary-antibodies-ab51564-1.jpg)
Overlay histogram showing peripheral blood lymphocytes stained with ab51564 (red line). The cells incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51564, 1 µl/1x106 cells) for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a FITC (1 µg/1x106 cells ) for 30 min at 22°C. Acquisition of >5,000 events was performed.
ab51564 has not yet been referenced specifically in any publications.
Publishing research using ab51564? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)](/ps/datasheet/images/51/ab51564/CD45RO-Primary-antibodies-ab51564-1.jpg)
Overlay histogram showing peripheral blood lymphocytes stained with ab51564 (red line). The cells incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51564, 1 µl/1x106 cells) for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a FITC (1 µg/1x106 cells ) for 30 min at 22°C. Acquisition of >5,000 events was performed.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
